» Articles » PMID: 19366914

Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses

Overview
Specialty Microbiology
Date 2009 Apr 16
PMID 19366914
Citations 1281
Authors
Affiliations
Soon will be listed here.
Abstract

The innate immune system constitutes the first line of defense against invading microbial pathogens and relies on a large family of pattern recognition receptors (PRRs), which detect distinct evolutionarily conserved structures on pathogens, termed pathogen-associated molecular patterns (PAMPs). Among the PRRs, the Toll-like receptors have been studied most extensively. Upon PAMP engagement, PRRs trigger intracellular signaling cascades ultimately culminating in the expression of a variety of proinflammatory molecules, which together orchestrate the early host response to infection, and also is a prerequisite for the subsequent activation and shaping of adaptive immunity. In order to avoid immunopathology, this system is tightly regulated by a number of endogenous molecules that limit the magnitude and duration of the inflammatory response. Moreover, pathogenic microbes have developed sophisticated molecular strategies to subvert host defenses by interfering with molecules involved in inflammatory signaling. This review presents current knowledge on pathogen recognition through different families of PRRs and the increasingly complex signaling pathways responsible for activation of an inflammatory and antimicrobial response. Moreover, medical implications are discussed, including the role of PRRs in primary immunodeficiencies and in the pathogenesis of infectious and autoimmune diseases, as well as the possibilities for translation into clinical and therapeutic applications.

Citing Articles

Cyclic N, O-acetals and corresponding opened N, N-aminals as new scaffolds with promising anti-inflammatory and antifungal activities against Candida albicans.

Safi C, Camaioni L, Othman M, Lambert D, Buisine M, Lawson A Sci Rep. 2025; 15(1):8364.

PMID: 40069300 PMC: 11897400. DOI: 10.1038/s41598-025-92635-z.


Decoy oligonucleotides targeting NF-κB: a promising therapeutic approach for inflammatory diseases.

Mahjoubin-Tehran M, Rezaei S, Butler A, Sahebkar A Inflamm Res. 2025; 74(1):47.

PMID: 40047902 DOI: 10.1007/s00011-025-02021-8.


The Role of Sustained Type I Interferon Secretion in Chronic HIV Pathogenicity: Implications for Viral Persistence, Immune Activation, and Immunometabolism.

Teer E, Mukonowenzou N, Essop M Viruses. 2025; 17(2).

PMID: 40006894 PMC: 11860620. DOI: 10.3390/v17020139.


Differential Expression of Key Immune Markers in the Intestinal Tract of Developing Chick Embryos.

Sharma S, Alizadeh M, Pratt S, Stamatikos A, Abdelaziz K Vet Sci. 2025; 12(2).

PMID: 40005946 PMC: 11860313. DOI: 10.3390/vetsci12020186.


The Interplay Between Immunity, Inflammation and Endothelial Dysfunction.

Chee Y, Dalan R, Cheung C Int J Mol Sci. 2025; 26(4).

PMID: 40004172 PMC: 11855323. DOI: 10.3390/ijms26041708.


References
1.
Barton G, Kagan J, Medzhitov R . Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol. 2005; 7(1):49-56. DOI: 10.1038/ni1280. View

2.
Chamaillard M, Hashimoto M, Horie Y, Masumoto J, Qiu S, Saab L . An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat Immunol. 2003; 4(7):702-7. DOI: 10.1038/ni945. View

3.
Mukherjee S, Keitany G, Li Y, Wang Y, Ball H, Goldsmith E . Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science. 2006; 312(5777):1211-4. DOI: 10.1126/science.1126867. View

4.
Boone D, Turer E, Lee E, Ahmad R, Wheeler M, Tsui C . The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol. 2004; 5(10):1052-60. DOI: 10.1038/ni1110. View

5.
Rotem Z, Cox R, Isaacs A . Inhibition of virus multiplication by foreign nucleic acid. Nature. 1963; 197:564-6. DOI: 10.1038/197564a0. View